The initiative comes days after the launch of the Brazilian Association of the Indian Pharmaceutical Industry in Brasilia, intended to act as an institutional bridge between Indian drugmakers and the Brazilian market by facilitating partnerships, investments and regulatory compliance.
CSIR-CDRI Director Radha Rangarajan, on Tuesday, stated the 'Uttar Pradesh Pharma Conclave 1.0' is one of the most crucial moments of the pharmaceutical industry and plays a major role in the industry's growth and expansion in the State.
Speaking on the Union Budget 2026-27, Indian Council of Medical Research (ICMR) Director General Rajiv Bahl noted that the government has initiated a significant push to transform the country's pharmaceutical landscape by addressing regulatory gaps and enhancing research infrastructure. S
The Union Budget 2026 has signalled a sustained policy push for India's pharmaceutical and life sciences sector, with a strong emphasis on biopharma innovation, research infrastructure and affordability, even as direct tax incentives remain unchanged, noted EY's Budget sectoral alert.
The India-New Zealand Free Trade Agreement (FTA) is expected to deliver a significant boost to India's exports, with New Zealand offering zero-duty market access on 100 per cent of its tariff lines covering all Indian exports from the date of entry into force.
A joint report by Confederation of Indian Industry (CII) and Deloitte called for a coordinated approach involving pharmaceutical enterprises, Government agencies, financial institutions, and Industry associations to embed sustainability across the value chain.
The growth of the Indian pharmaceuticals market (IPM) continues to remain muted in November, staying in single-digit territory for the past 32 months, Nomura said in its latest report.
The report mentioned that India's pharmaceutical industry is entering a decisive new phase marked by tighter supply chains, sustainable manufacturing pressures and an accelerated global shift toward advanced biologics.
According to an official release from the Ministry of AYUSH, the two-day national conclave has been organised by the Regional Ayurveda Research Institute (RARI), Vijayawada, in collaboration with the Confederation of Indian Industry (CII), Vijayawada Zone.
Union Minister of Commerce and Industry, Piyush Goyal, held an interaction with key stakeholders from India's pharmaceutical ecosystem, focusing on strengthening industry growth and regulatory reforms.
India's pharmaceutical exports are nearing the USD 30-billion mark, setting the stage for the next phase of industry innovation powered by Contract Research and Development Organisations (CRDMOs) and Global Capability Centers (GCCs), according to a new EY-Parthenon-OPPI report.